Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02743819 |
|---|---|
| Brief Title: | Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma |
| First Submitted : | April 14, 2016 |
| First Submitted that Met QC Criteria : | April 15, 2016 |
| First Posted : | April 19, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 25, 2020 |
| Last Update Posted : | September 29, 2020 |